FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

34161411000001104: Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
103589301000001110 Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
103589401000001119 Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) Is a Trifluoperazine 5mg tablets true Inferred relationship Existential restriction modifier
Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) Is a Trifluoperazine 5mg tablets false Inferred relationship Existential restriction modifier
Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) Is a Product containing precisely trifluoperazine 5 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) Has active ingredient Trifluoperazine false Inferred relationship Existential restriction modifier
Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) Has specific active ingredient Trifluoperazine hydrochloride true Inferred relationship Existential restriction modifier
Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Trifluoperazine true Inferred relationship Existential restriction modifier
Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) Has basis of strength substance Trifluoperazine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) 112 tablet Has AMP True Trifluoperazine 5mg tablets (Ennogen Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start